WALTHAM, Mass.–(BUSINESS WIRE)–#chronicpain–NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell® Wearable
Pain Relief Technology™ will be featured at SLEEP 2016, which
is a joint meeting of the American Academy of Sleep Medicine and the
Sleep Research Society. The meeting takes place June 11-15 in Denver, CO.
There are over 100 million Americans with chronic pain. According to the
American Academy of Pain Medicine, 86% of people with chronic pain
report an inability to sleep well. Quell utilizes neurostimulation
technology to provide relief from chronic pain. The wearable device is
lightweight and can be worn during the day while active, and at night
while sleeping. Quell objectively tracks utilization and various health
metrics including sleep. In a recent study of Quell, 81% of participants
reported improvement in their chronic pain on the Patient Global
Impression of Change (PGIC) scale. In addition, participants reported a
statistically and clinically significant reduction in pain interference
with sleep. Please visit www.QuellRelief.com
to learn more about Quell.
“We are pleased to take part in SLEEP 2016 and will share the role that
Quell’s innovative technology can play in improving sleep for chronic
pain sufferers,” said Shai N. Gozani, M.D., Ph.D., President and Chief
Executive Officer of NeuroMetrix.
Two scientific posters on Quell technology will be presented.
“Impact of Transcutaneous Electrical Nerve Stimulation (TENS) Therapy
on Sleep Efficiency in Subjects with Chronic Pain.” Sunday June 12
from 5:00 PM – 7:00 PM.
“Pilot Open-label Trial Of Transcutaneous Electrical Nerve Stimulation
(TENS) Below The Knee For The Treatment Of Restless Legs Syndrome
(RLS).” Monday June 13 from 4:00 PM – 6:00 PM.
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
Thomas T. Higgins, 781-314-2761
Chief Financial Officer